Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
By N. Marrouche, D. Wilber, Gerhard Hindricks, P. Jais, N. Akoum, F. Marchlinski, E. Kholmovski, N. Burgon, Nan Hu, L. Mont and 10 more. Journal of the American Medical Association (JAMA), 2014
1,413 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/93c25cb89a3e01d95bce3c789f746fb1c4859687
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, background): “with lower efficacy, was confirmed in the multicenter Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation (DECAAF) study.(365) On the other hand, these MRI findings at this point in time require extensive MRI experience, including specification of image contrast and continuity, require”
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “1 Outcome of catheter ablation for atrial fibrillation The rhythm outcome after catheter ablation of AF is difficult to predict in individual patients.(173,227,713,728) Most patients require more than one procedure to achieve symptom control.”
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016, positive): “Magnetic resonance imaging techniques attempting to characterize the extent of myocardial fibrosis have demonstrated that this appears to be the strongest independent predictor of AF recurrence after ablation.(416,454) Whether the EHRAS classification has value for informing catheter ablation in hum”